Large-scale testing (Phase 3)Study completedNCT00260832What this trial is testingTrial of Decitabine in Patients With Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Eisai Inc. 485
Early research (Phase 1)Study completedNCT04714372What this trial is testingFT538 in Combination With Daratumumab in AML Acute Myeloid LeukemiaWho this might be right forAcute Myeloid LeukemiaMyeloid LeukemiaMonocytic Leukemia Masonic Cancer Center, University of Minnesota 9
Very early researchLooking for participantsNCT06398457What this trial is testingDarzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific AntibodiesWho this might be right forHematologic MalignancyBone Marrow Transplant RejectionAcute Myeloid Leukemia (AML)+9 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Not applicableUnknownNCT03450512What this trial is testingIncidence of Neutropenic Enterocolitis Study in Acute Myeloid Leukemia Patients During Intensive TherapyWho this might be right forAcute Myeloid Leukemia Centre Hospitalier Universitaire, Amiens 170
Testing effectiveness (Phase 2)Ended earlyNCT02418000What this trial is testingE6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras MutationsWho this might be right forAMLMDSCMML Spirita Oncology, LLC 27
Not applicableLooking for participantsNCT06782971What this trial is testingEvaluation of Combined Sensitising and Hypomethylating Therapy Outcomes in AML PDXWho this might be right forAML - Acute Myeloid Leukemia Clinical Hub for Interventional Research (CHOIR) 25
Testing effectiveness (Phase 2)Study completedNCT00049192What this trial is testingOblimersen and Imatinib Mesylate in Treating Patients With Chronic Myelogenous LeukemiaWho this might be right forChronic Myelogenous Leukemia, BCR-ABL1 PositiveChronic Phase Chronic Myelogenous LeukemiaRelapsing Chronic Myelogenous Leukemia National Cancer Institute (NCI) 43
Early research (Phase 1)Study completedNCT03358719What this trial is testingDEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid LeukemiaWho this might be right forAcute Myeloid LeukemiaBlasts 30 Percent or Less of Bone Marrow Nucleated CellsChronic Myelomonocytic Leukemia+3 more Roswell Park Cancer Institute 8
Not applicableStudy completedNCT00899652What this trial is testingDNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaWho this might be right forLeukemia Children's Oncology Group 149
Not applicableStudy completedNCT02921815What this trial is testingAnalyze the Occurrence of Transformation From Myelodysplastic Syndrome to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndrome Who Received Revlimid® 5 mg Capsules and Who Are Continuing or no Longer Continuing Revlimid TreatmentWho this might be right forMyelodysplastic SyndromesLeukemia, Myeloid, Acute Celgene 84
Testing effectiveness (Phase 2)Active Not RecruitingNCT05143840What this trial is testingAsciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic PhaseWho this might be right forChronic Myeloid Leukemia, Chronic PhaseAdult CMLLeukemia, Myeloid+1 more University of Alabama at Birmingham 100
Testing effectiveness (Phase 2)Study completedNCT01912274What this trial is testingSafety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloid Leukemia Helsinn Healthcare SA 50
Testing effectiveness (Phase 2)Study completedNCT00363649What this trial is testingInterferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKIWho this might be right forLeukemia Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 36
Large-scale testing (Phase 3)Study completedNCT00931138What this trial is testingTreatment of Acute Myeloid Leukemia (AML) in Adults 50 to 70 Years, Study of Two Anthracyclines and the Interest of Maintenance Treatment With Interleukin 2Who this might be right forAcute Myeloid Leukemia Acute Leukemia French Association 420
Not applicableEnded earlyNCT00594308What this trial is testingIn-Vivo Activated T-Cell Depletion to Prevent GVHDWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+7 more Indiana University 10
Testing effectiveness (Phase 2)Ended earlyNCT05358808What this trial is testingACHIEVE - Efficacy and Effectiveness of Adoptive Cellular tHerapy wIth Ex-Vivo Expanded Allogeneic γδ T-lymphocytes (TCB008) for Patients With Refractory or Relapsed Acute Myeloid Leukaemia (AML)Who this might be right forAcute Myeloid LeukemiaMyelodysplastic Syndromes TC Biopharm 16
Early research (Phase 1)Active Not RecruitingNCT05001828What this trial is testingStudy of ADI-PEG 20, Venetoclax and Azacitidine in Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia, Adult Polaris Group 38
Not applicableLooking for participantsNCT06724536What this trial is testingInteraction Between Gut Microbiota and TKIs in Defining the Clinical Outcomes of Patients With CMLWho this might be right forLeukemia,Myeloid, Chronic Carmen Fava 100
Not applicableStudy completedNCT01321385What this trial is testingBiomarkers in Predicting Response to Treatment in Bone Marrow Samples From Young Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia Children's Oncology Group 97
Not applicableStudy completedNCT00478985What this trial is testingEvaluation of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid LeukemiaWho this might be right forMyeloid Leukemia, Chronic University Hospital, Bordeaux 100